论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
基于术前指标的新型评分模型对乳腺癌脊柱转移瘤(BCSM)患者的预后意义
Authors Zhao C, Wang Y, Cai X, Xu W, Wang D, Wang T, Jia Q, Gong H, Sun H, Wu Z, Xiao J
Received 29 July 2020
Accepted for publication 15 October 2020
Published 10 November 2020 Volume 2020:12 Pages 11501—11513
DOI https://doi.org/10.2147/CMAR.S273785
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Sanjeev Srivastava
Background: Surgery remains the mainstay of treatment for breast cancer spinal metastasis (BCSM) to relieve symptoms and improve the quality of life of BCSM patients. Therefore, it is important to effectively predict the prognosis of patients to determine whether they can undergo surgical operation. However, the prevalent methods for prognosis evaluation lack specificity and sensitivity for indicated malignancies like breast cancer because they are built on a relatively small number of heterogeneous types of primary tumors. The aim of the present study was to explore a novel predictive model based on the clinical, pathological and blood parameters obtained from BCSM patients before they received surgical intervention.
Methods: Altogether, 144 patients were included in this study. Univariate and multivariate analyses were performed to investigate the significance of preoperative parameters and identify independent factors for prognostic prediction of BCSM. A nomogram for survival prediction was then established and validated. Time-dependent ROC (TDROC) curves were graphed to evaluate the accuracy of the novel model vs other scoring systems including Tomita Score, revised Tokuhashi Score, modified Bauer Score and New England Spinal Metastasis Score. P values < 0.05 were considered statistically significant.
Results: Independent factors, including preoperative postmenopausal (P =0.034), visceral metastasIs (P =0.021), preoperative Frankel Score (P =0.001), estrogen receptor status (P =0.014), platelet-to-lymphocyte ratio (P =0.012), lymphocyte-monocyte ratio (P < 0.001) and albumin-globulin ratio (P =0.017), were selected into the nomogram model with the C-index of 0.834 (95% CI, 0.789– 0.890). TDROC curves showed that the Changzheng Hospital (CZ) Score system had the best performance and exhibited the largest IAUC value in comparison with the other scoring systems.
Conclusion: We constructed a nomogram model known as CZ Score based on the significant factors to predict the prognosis for BCSM patients. The result showed that CZ Score had a better value for prognostic evaluation and surgical decision-making as compared with the other scoring systems.
Keywords: breast cancer, spine metastases, nomogram, scoring system, prognosis